alvespimycin vs bdb
Mechanistic comparison of alvespimycin and bdb chembl3786596 us9611221 example 42 us10179769 example 42 us9725441 example 42 us based on molecular target overlap from BindingDB and ChEMBL binding affinity data.
2
Shared Targets
29%
Jaccard Similarity
32%
IDF-Weighted Similarity
Jaccard measures raw target overlap. IDF-weighted downweights promiscuous hub targets (e.g. CYP enzymes) that bind many compounds non-specifically.
Evidence Comparison
Target Overlap
alvespimycin and bdb share 2 molecular targets based on binding affinity data from BindingDB (Kd/IC50 ≤ 10 µM) and ChEMBL. A Jaccard index of 0.286 means 29% of the combined target set is bound by both compounds. The IDF-weighted score of 0.319 accounts for non-specific binding to metabolic enzymes.
Note: High target overlap does not imply identical mechanism or therapeutic equivalence. Binding affinity, tissue distribution, bioavailability, and downstream signaling differ significantly between compounds even when they bind the same protein.